{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:21:24Z","timestamp":1792002084959,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Province Medical Health Science and Technology Plan Project","award":["2018KY566"],"award-info":[{"award-number":["2018KY566"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08078-x","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T23:02:13Z","timestamp":1756681333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Siying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"8078_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.","journal-title":"Lancet"},{"key":"8078_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jvh.12757","volume":"25","author":"H Zheng","year":"2018","unstructured":"Zheng H, Cui FQ, Wang FZ, Huang LF, Shao XP, Du JF, et al. The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China. J Viral Hepat. 2018;25:88\u201396.","journal-title":"J Viral Hepat"},{"key":"8078_CR3","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.1038\/s41598-017-12005-2","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhou H, Zhang L, Zhong Q, Wang Q, Shen H, et al. Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China. Sci Rep. 2017;7:12090.","journal-title":"Sci Rep"},{"key":"8078_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jcv.2016.05.014","volume":"81","author":"X Xin","year":"2016","unstructured":"Xin X, Wang Y, Cheng J, Zhang Y, Peng Z, Xu J, et al. Seroepidemiological survey of hepatitis B virus infection among 764,460 women of childbearing age in rural China: a cross-sectional study. J Clin Virol. 2016;81:47\u201352.","journal-title":"J Clin Virol"},{"key":"8078_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12072-021-10285-5","volume":"16","author":"M Kumar","year":"2022","unstructured":"Kumar M, Abbas Z, Azami M, Belopolskaya M, Dokmeci AK, Ghazinyan H, et al. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatol Int. 2022;16:211\u201353.","journal-title":"Hepatol Int"},{"key":"8078_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/14760584.2021.1927723","volume":"20","author":"B Xu","year":"2021","unstructured":"Xu B, Xu C, Feng J, Chen J, Rui Y, Qiu Z, et al. Reduced mother-to-child transmission of hepatitis B after implementation of completely charge-free active-passive immunoprophylaxis: an observational cohort study. Expert Rev Vaccines. 2021;20:899\u2013905.","journal-title":"Expert Rev Vaccines"},{"key":"8078_CR7","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.vaccine.2017.10.032","volume":"35","author":"Y Lu","year":"2017","unstructured":"Lu Y, Zhu FC, Liu JX, Zhai XJ, Chang ZJ, Yan L, et al. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: a large prospective cohort study in China. Vaccine. 2017;35:6627\u201333.","journal-title":"Vaccine"},{"key":"8078_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"EASL","year":"2017","unstructured":"EASL. 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370\u201398.","journal-title":"J Hepatol"},{"key":"8078_CR9","first-page":"769","volume":"9","author":"G Wang","year":"2021","unstructured":"Wang G, Duan Z. Guidelines for prevention and treatment of chronic hepatitis B. J Clin Transl Hepatol. 2021;9:769\u201391.","journal-title":"J Clin Transl Hepatol"},{"key":"8078_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok A, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560\u201399.","journal-title":"Hepatology"},{"key":"8078_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jfma.2018.11.008","volume":"118","author":"RN Chien","year":"2019","unstructured":"Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, et al. Taiwan consensus statement on the management of chronic hepatitis B. J Formos Med Assoc. 2019;118:7\u201338.","journal-title":"J Formos Med Assoc"},{"key":"8078_CR12","volume-title":"Child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy","author":"Prevention of Mother-to","year":"2020","unstructured":"Prevention of Mother-to-. Child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020."},{"key":"8078_CR13","first-page":"1309","volume":"30","author":"[Guidelines for the prevention","year":"2022","unstructured":"[Guidelines for the prevention. And treatment of chronic hepatitis B (version 2022)]. Zhonghua Gan Zang Bing Za Zhi. 2022;30:1309\u201331.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"8078_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41395-018-0010-2","volume":"113","author":"W Yi","year":"2018","unstructured":"Yi W, Pan CQ, Li MH, Wan G, Lv YW, Liu M, et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B. Am J Gastroenterol. 2018;113:686\u201393.","journal-title":"Am J Gastroenterol"},{"key":"8078_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jgh.13436","volume":"32","author":"J Liu","year":"2017","unstructured":"Liu J, Wang J, Jin D, Qi C, Yan T, Cao F, et al. Hepatic flare after Telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus. J Gastroenterol Hepatol. 2017;32:177\u201383.","journal-title":"J Gastroenterol Hepatol"},{"key":"8078_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12072-022-10412-w","volume":"17","author":"M Li","year":"2023","unstructured":"Li M, Sun F, Bi X, Lin Y, Yang L, Jiang T, et al. Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection. Hepatol Int. 2023;17:42\u201351.","journal-title":"Hepatol Int"},{"key":"8078_CR17","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/jmv.26011","volume":"92","author":"LX Xiao","year":"2020","unstructured":"Xiao LX, Chen YR, Huang P, Mei YY, Pan CQ, Lin CS. The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy. J Med Virol. 2020;92:3381\u20139.","journal-title":"J Med Virol"},{"key":"8078_CR18","doi-asserted-by":"publisher","first-page":"15514","DOI":"10.1038\/s41598-018-33833-w","volume":"8","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu Y, Ding G, Touqui L, Wang W, Xu N, et al. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Sci Rep. 2018;8:15514.","journal-title":"Sci Rep"},{"key":"8078_CR19","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jhep.2020.01.021","volume":"72","author":"WH Wen","year":"2020","unstructured":"Wen WH, Chen HL, Shih TT, Wu JF, Ni YH, Lee CN, et al. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to Tenofovir disoproxil fumarate. J Hepatol. 2020;72:1082\u20137.","journal-title":"J Hepatol"},{"key":"8078_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/gutjnl-2020-322719","volume":"71","author":"CQ Pan","year":"2022","unstructured":"Pan CQ, Dai E, Duan Z, Han G, Zhao W, Wang Y, et al. Long-term safety of infants from mothers with chronic hepatitis B treated with Tenofovir disoproxil in China. Gut. 2022;71:798\u2013806.","journal-title":"Gut"},{"key":"8078_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/liv.13594","volume":"38","author":"T Kushner","year":"2018","unstructured":"Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study. Liver Int. 2018;38:813\u201320.","journal-title":"Liver Int"},{"key":"8078_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12072-008-9063-4","volume":"2","author":"HH Tan","year":"2008","unstructured":"Tan HH, Lui HF, Chow WC. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int. 2008;2:370\u20135.","journal-title":"Hepatol Int"},{"issue":"12","key":"8078_CR23","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/jmv.26011","volume":"92","author":"LX Xiao","year":"2020","unstructured":"Xiao LX, Chen YR, Huang P, Mei YY, Pan CQ, Lin CS. The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy. J Med Virol. 2020;92(12):3381\u20139. https:\/\/doi.org\/10.1002\/jmv.26011","journal-title":"J Med Virol"},{"key":"8078_CR24","doi-asserted-by":"publisher","first-page":"893628","DOI":"10.3389\/fimmu.2022.893628","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F, Xie S, Ran C, Hao H, Jiang T, Deng W, et al. Effect of antiviral therapy during pregnancy on natural killer cells in pregnant women with chronic HBV infection. Front Immunol. 2022;13:893628.","journal-title":"Front Immunol"},{"key":"8078_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20061287","volume":"204","author":"C Dunn","year":"2007","unstructured":"Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med. 2007;204:667\u201380.","journal-title":"J Exp Med"},{"key":"8078_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1600-0897.1997.tb00246.x","volume":"37","author":"M Watanabe","year":"1997","unstructured":"Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y, Amino N. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol. 1997;37:368\u201377.","journal-title":"Am J Reprod Immunol"},{"key":"8078_CR27","doi-asserted-by":"publisher","first-page":"1112234","DOI":"10.3389\/fimmu.2022.1112234","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Jiang T, Yang Y, Deng W, Lu H, Wang S, et al. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection. Front Immunol. 2022;13:1112234.","journal-title":"Front Immunol"},{"key":"8078_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7150\/ijms.79663","volume":"20","author":"M Zhou","year":"2023","unstructured":"Zhou M, Cai H, Yi W, Gao X. A nonlinear relationship between ALT levels at delivery and the risk of postpartum ALT flares in pregnant women with chronic hepatitis B. Int J Med Sci. 2023;20:247\u201353.","journal-title":"Int J Med Sci"},{"key":"8078_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13006-021-00388-y","volume":"16","author":"H Shi","year":"2021","unstructured":"Shi H, Yang Y, Yin X, Li J, Fang J, Wang X. Determinants of exclusive breastfeeding for the first six months in China: a cross-sectional study. Int Breastfeed J. 2021;16:40.","journal-title":"Int Breastfeed J"},{"key":"8078_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106726","volume":"61","author":"S Li","year":"2023","unstructured":"Li S, Jin J, Jiang Y, Shi J, Jiang X, Lin N, Ma Z. Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate. Int J Antimicrob Agents. 2023;61: 106726.","journal-title":"Int J Antimicrob Agents"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08078-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:42:54Z","timestamp":1757482974000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08078-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8078"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08078-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of Helsinki and approved by the Ethics Committee of Hangzhou First People\u2019s Hospital (2017 Research Medical Review No. 116-01), and all participants provided written informed consent before their enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors had reviewed and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"900"}}